Evidence map›Paper›PMID 30720439›Full record

ArticleJMIR mHealth and uHealth2019

Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.

Revital Azulay, Liora Valinsky, Fabienne Hershkowitz, Racheli Magnezi

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03642652 (Repeated Automated Mobile Text Reminders for Follow-up of Positive Fecal Occult Blood Tests), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03642652 nacompletednot on this map

Repeated Automated Mobile Text Reminders for Follow-up of Positive Fecal Occult Blood Tests: a Randomized Controlled Trial

TypeinterventionalSponsorMeuhedet. Healthcare OrganizationRan2016 to 2017Enrolled470ConditionsColorectal CancerArmsSMS
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Examining the Factors That Affect the Diagnosis of Patients with Positive Fecal Occult Blood Test Results.International journal of environmental research and public health · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CRC Screening Results: Patient Comprehension and Follow-up.Cancer control : journal of the Moffitt Cancer Center
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Revital Azulay *Master of Health Administration Program, Department of Management, Bar Ilan University, Ramat Gan, Israel.ORCID 0000-0002-7523-0156
Liora Valinsky *Quality Department, Meuhedet Health Care, Tel Aviv, Israel.ORCID 0000-0003-0285-6681
Fabienne Hershkowitz *Quality Department, Meuhedet Health Care, Tel Aviv, Israel.ORCID 0000-0001-6251-5219
Racheli Magnezi *Master of Health Administration Program, Department of Management, Bar Ilan University, Ramat Gan, Israel.ORCID 0000-0003-1944-5897
Bar-Ilan University · ILClalit Health Services · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFecal occult blood tests (FOBTs) are recommended by the US Preventive Services Task Force as a screening method for colorectal cancer (CRC), but they are only effective if positive results are followed by colonoscopy. Surprisingly, a large proportion of patients with a positive result do not follow this recommendation.

objectiveThe objective of this study was to examine the effectiveness of text messaging (short message service, SMS) in increasing adherence to colonoscopy follow-up after a positive FOBT result.

methodsThis randomized controlled trial was conducted with patients who had positive CRC screening results. Randomization was stratified by residential district and socioeconomic status (SES). Subjects in the control group (n=238) received routine care that included an alert to the physician regarding the positive FOBT result. The intervention group (n=232) received routine care and 3 text messaging SMS reminders to visit their primary care physician. Adherence to colonoscopy was measured 120 days from the positive result. All patient information, including test results and colonoscopy completion, were obtained from their electronic medical records. Physicians of study patients completed an attitude survey regarding FOBT as a screening test for CRC. Intervention and control group variables (dependent and independent) were compared using chi-square test. Logistic regression was used to calculate odds ratios (ORs) and 95% CIs for performing colonoscopy within 120 days for the intervention group compared with the control group while adjusting for potential confounders including age, gender, SES, district, ethnicity, and physicians' attitude.

resultsOverall, 163 of the 232 patients in the intervention group and 112 of the 238 patients in the control group underwent colonoscopy within 120 days of the positive FOBT results (70.3% vs 47.1%; OR 2.17, 95% CI 1.49-3.17; P<.001); this association remained significant after adjusting for potential confounders (P=.001).

conclusionsA text message (SMS) reminder is an effective, simple, and inexpensive method for improving adherence among patients with positive colorectal screening results. This type of intervention could also be evaluated for other types of screening tests.

trial registrationClinicalTrials.gov NCT03642652; https://clinicaltrials.gov/ct2/show/NCT03642652 (Archived by WebCite at http://www.webcitation.org/74TlICijl).

Indexed as

Occult BloodAftercareAgedColorectal NeoplasmsFemaleHumansMaleMass ScreeningMiddle AgedMobile ApplicationsReminder SystemsText MessagingTreatment Adherence and Complianceadherencecancer screeningcolonoscopyfetal occult blood testpatient-physician relationshippositive colorectal cancer screeningSMStext reminder

Identifiers

PMID30720439
PMCPMC6379817
OpenAlexW2898093127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.